Literature DB >> 32247146

Application of RRLC-QTOF-MS-based metabonomics and UPE for investigating Spleen-Qi deficiency syndrome with Panax ginseng treatment.

Ni Wang1, Xin Huang2, Tie Li3, Mei Wang4, Hao Yue1, Changbao Chen1, Shuying Liu5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Spleen-Qi deficiency is a syndrome of traditional Chinese medicine. Panax ginseng (ginseng) is well known as the key herb for replenishing Qi and tonifying Spleen. However, the pathogenesis of Spleen-Qi deficiency syndrome and therapeutic mechanism of ginseng on Spleen-Qi deficiency constitution have not yet been entirely elucidated. AIM OF THE STUDY: The aim of this work was to investigate the pathogenesis of Spleen-Qi deficiency syndrome and therapeutic mechanism of ginseng on Spleen-Qi deficiency constitution.
MATERIALS AND METHODS: The urinary metabonomics was investigated before and after ginseng treatment in Spleen-Qi deficiency subjects by rapid resolution liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (RRLC-QTOF-MS). The spectra of metabolites were analyzed by principal component analysis (PCA) and the score showed significant difference among the three different groups. The serum biochemical parameters creatine kinases (CK), lactate dehydrogenase (LDH), interferon-γ (INF-γ), Interleukin-4 (IL-4), superoxide dismutase (SOD) and malondialdehyde (MDA) were determined by assay kits. In addition, ultraweak photon emission (UPE) intensity was measured at dazhui point in each subject.
RESULTS: According to the orthogonal partial least-squares discriminant analysis (OPLS-DA) results and biochemistry databases searching, 15 potential biomarkers were identified to be involved in Spleen-Qi deficiency syndrome and ginseng influenced Spleen-Qi deficiency. The metabonomics and biological experiment data indicated that metabolism pathways were corresponding to energy metabolism, amino acid, carbohydrate, lipid and pyrimidine metabolisms, oxidative stress urea cycle, and intestinal flora metabolism. And the UPE intensity decreased significantly after the treatment.
CONCLUSIONS: Ginseng could promote the related metabolisms in Spleen-Qi deficiency constitution and the metabolites and UPE intensity may be useful as potential biomarkers for diagnosing and monitoring for Spleen-Qi deficiency syndrome.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabonomics; Panax ginseng; Spleen-qi deficiency syndrome; Ultraweak photon emission

Mesh:

Substances:

Year:  2020        PMID: 32247146     DOI: 10.1016/j.jep.2020.112822

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats.

Authors:  Yu You; Lin Luo; Yanyan You; Yanjun Lin; Huiling Hu; Yunhui Chen; Chaomei Fu; Tian Xie
Journal:  Chin Med       Date:  2020-10-28       Impact factor: 5.455

2.  Chemical Fingerprint Analysis and Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Study of the Protective Effect of Buxue Yimu Granule in Medical-Induced Incomplete Abortion Rats.

Authors:  Yan Zhang; Wei Li; Ting-Ting Chen; Yong Yang; Meng-Yao Wu; Jie-Ying Luo; Yun Gong; Liang Zou
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

3.  Ginseng adjuvant therapy on COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Hang Shi; Yawen Xia; Renjun Gu; Shuang Yu
Journal:  Medicine (Baltimore)       Date:  2021-10-29       Impact factor: 1.889

4.  Codonopsis pilosula Polysaccharide Improved Spleen Deficiency in Mice by Modulating Gut Microbiota and Energy Related Metabolisms.

Authors:  Lingya Cao; Changli Du; Xiaolu Zhai; Jiankuan Li; Jingyi Meng; Yunyun Shao; Jianping Gao
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

5.  Study on the mechanism of Ginseng-Gegen for mesenteric lymphadenitis based on network pharmacology.

Authors:  Yanxia Zheng; Zhuoxun Liu; Aiyuan Cai; Siting Xu; Zelin Weng; Wenying Gao; Youjia Xu
Journal:  Transl Pediatr       Date:  2022-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.